JESSICA CAIN: Open Payments
NPI 1235178302 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,248 in 142 payments from 25 companies in 2025. Trend: 2023 $10,058 · 2024 $15,384 · 2025 $13,248
Speaker / faculty: $4,813Honoraria: $4,713Food & beverage: $2,647Consulting: $550Travel & lodging: $526
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $5,284 |
| Axsome Therapeutics, Inc. | 12 | $5,203 |
| Merz Pharmaceuticals, LLC | 5 | $639 |
| TG Therapeutics, Inc. | 12 | $348 |
| Novartis Pharmaceuticals Corporation | 9 | $187 |
| Amgen Inc. | 9 | $176 |
| UCB, Inc. | 8 | $169 |
| Celgene Corporation | 15 | $150 |
| Biogen, Inc. | 8 | $144 |
| Amneal Pharmaceuticals LLC | 11 | $136 |
Products named: Symbravo, QULIPTA, UBRELVY, INBRIJA, BRIUMVI, KESIMPTA, UPLIZNA, ZEPOSIA.
Industry payments across VA — which companies pay providers there.
